Your browser doesn't support javascript.
loading
Impact Of body Mass Index on Cardiopulmonary Outcomes of COVID-19 Hospitalizations Complicated by Severe Sepsis.
Neppala, Sivaram; Chigurupati, Himaja Dutt; Mopuru, Nikhilender Nag; Alle, Naga Ruthvika; James, Alpha; Bhalodia, Ami; Shaik, Sajida; Bandaru, Revanth Reddy; Nanjundappa, Athmananda; Sunkara, Praveena; Gummadi, Jyotsna; Desai, Rupak.
Affiliation
  • Neppala S; University of Texas at San Antonio, San Antonio, TX, USA.
  • Chigurupati HD; Department of Medicine, New York Medical College at Saint Michael's Medical Center, Newark, NJ, USA.
  • Mopuru NN; Department of Medicine, Kamineni Academy of medical sciences and research Centre, Hyderabad, India.
  • Alle NR; Department of Medicine, Narayana Medical College, Nellore, India.
  • James A; Department of Medicine, Bukovinian State Medical University, Chernivitsi, Ukraine.
  • Bhalodia A; Department of Medicine, Pandit Deendayal Upadhyay Medical College, Gujrat, India.
  • Shaik S; Department of Medicine, Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Andhra Pradesh, India.
  • Bandaru RR; Department of Medicine, East Carolina University, Greenville, NC, USA.
  • Nanjundappa A; Department of Medicine, MedStar Franklin Square Medical Center, Baltimore, MD, USA.
  • Sunkara P; Department of Medicine, Medstar Medical group, Charlotte Hall, MD, USA.
  • Gummadi J; Department of Medicine, MedStar Franklin Square Medical Center, Baltimore, MD, USA.
  • Desai R; Independent Outcomes Researcher, Atlanta, GA, USA.
Obes Pillars ; 10: 100101, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38435542
ABSTRACT

Background:

Body Mass Index (BMI) has a significant impact on Coronavirus disease (COVID-19) patient outcomes; however, major adverse cardiac and cerebrovascular outcomes in patients with severe sepsis have been poorly understood. Our study aims to explore and provide insight into its association.

Methods:

This is an observational study looking at the impact of BMI on COVID-19-severe sepsis hospitalizations. The primary outcomes are adjusted odds of all-cause in-hospital mortality, respiratory failure, and major adverse cardiac and cerebrovascular events (MACCE), which include acute myocardial infarction, cardiac arrest, and acute ischemic stroke. The secondary outcome was healthcare resource utilization. Coexisting comorbidities and patient features were adjusted with multivariable regression analyses.

Results:

Of 51,740 patients with severe COVID-19-sepsis admissions, 11.4% were overweight, 24.8% had Class I obesity (BMI 30-34.9), 19.8% had Class II obesity (BMI 35-39.9), and 43.9% had the categorization of Class III obesity (BMI >40) cohorts with age>18 years. The odds of MACCE in patients with class II obesity and class III obesity (OR 1.09 and 1.54; 95CI 0.93-1.29 and 1.33-1.79) were significantly higher than in overweight (p < 0.001). Class I, Class II, and Class III patients with obesity revealed lower odds of respiratory failure compared to overweight (OR 0.89, 0.82, and 0.82; 95CI 0.75-1.05, 0.69-0.97, and 0.70-0.97), but failed to achieve statistical significance (p = 0.079). On multivariable regression analysis, all-cause in-hospital mortality revealed significantly higher odds in patients with Class III obesity, Class II, and Class I (OR 1.56, 1.17, and 1.06; 95CI 1.34-1.81, 0.99-1.38, and 0.91-1.24) vs. overweight patients (p < 0.001).

Conclusions:

Patients with Class II and Class III obesity had significantly higher odds of MACCE and in-hospital mortality in COVID-19-severe sepsis admissions.
Key words

Full text: 1 Database: MEDLINE Language: En Journal: Obes Pillars Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Language: En Journal: Obes Pillars Year: 2024 Type: Article Affiliation country: United States